title: Regulation of tonic GABA inhibitory function, presympathetic neuronal activity and sympathetic outflow from the paraventricular nucleus by astroglial GABA transporters.
abstract: Neuronal activity in the hypothalamic paraventricular nucleus (PVN), as well as sympathetic outflow from the PVN, is basally restrained by a GABAergic inhibitory tone. We recently showed that two complementary GABA(A) receptor-mediated modalities underlie inhibition of PVN neuronal activity: a synaptic, quantal inhibitory modality (IPSCs, I(phasic)) and a sustained, non-inactivating modality (I(tonic)). Here, we investigated the role of neuronal and/or glial GABA transporters (GATs) in modulating these inhibitory modalities, and assessed their impact on the activity of RVLM-projecting PVN neurons (PVN-RVLM neurons), and on PVN influence of renal sympathetic nerve activity (RSNA). Patch-clamp recordings were obtained from retrogradely labelled PVN-RVLM neurons in a slice preparation. The non-selective GAT blocker nipecotic acid (100-300 microM) caused a large increase in GABA(A)I(tonic), and reduced IPSC frequency. These effects were replicated by beta-alanine (100 microM), but not by SKF 89976A (30 microM), relatively selective blockers of GAT3 and GAT1 isoforms, respectively. Similar effects were evoked by the gliotoxin L-alpha-aminodipic acid (2 mM). GAT blockade attenuated the firing activity of PVN-RVLM neurons. Moreover, PVN microinjections of nipecotic acid in the whole animal diminished ongoing RSNA. A robust GAT3 immunoreactivity was observed in the PVN, which partially colocalized with the glial marker GFAP. Altogether, our results indicate that by modulating ambient GABA levels and the efficacy of GABA(A)I(tonic), PVN GATs, of a likely glial location, contribute to setting a basal tone of PVN-RVLM firing activity, and PVN-driven RSNA.
authors.affiliation: Department of Physiology, Medical College of Georgia, 1120 15th St, Augusta, GA 30912, USA.
authors.forename: Jin Bong
authors.initials: JB
authors.lastname: Park
authors.forename: Ji Yoon
authors.initials: JY
authors.lastname: Jo
authors.forename: Hong
authors.initials: H
authors.lastname: Zheng
authors.forename: Kaushik P
authors.initials: KP
authors.lastname: Patel
authors.forename: Javier E
authors.initials: JE
authors.lastname: Stern
mesh_terms: D015074:2-Aminoadipic Acid / Q000494:pharmacology; D000818:Animals; D001253:Astrocytes / Q000502:physiology*; D055724:Electrophysiological Phenomena; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D018756:GABA Antagonists / Q000494:pharmacology*; D050485:GABA Plasma Membrane Transport Proteins / Q000502:physiology*; D058787:GABA-A Receptor Antagonists; D066298:In Vitro Techniques; D053444:Inhibitory Postsynaptic Potentials; D008297:Male; D009434:Neural Pathways / Q000187:drug effects / Q000502:physiology; D010286:Paraventricular Hypothalamic Nucleus / Q000187:drug effects* / Q000502:physiology*; D018408:Patch-Clamp Techniques; D051381:Rats; D017208:Rats, Wistar; D011963:Receptors, GABA-A / Q000502:physiology; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000502:physiology
chemical_list: D018691:Excitatory Amino Acid Antagonists; D018756:GABA Antagonists; D050485:GABA Plasma Membrane Transport Proteins; D058787:GABA-A Receptor Antagonists; D011963:Receptors, GABA-A; D015074:2-Aminoadipic Acid
references.citation: Am J Physiol Heart Circ Physiol. 2006 Mar;290(3):H1110-9
references.pmid: 16243912
references.citation: Hypertension. 2002 Feb;39(2):275-80
references.pmid: 11847197
references.citation: J Neurophysiol. 2006 May;95(5):2796-807
references.pmid: 16452257
references.citation: Endocrinology. 2006 Aug;147(8):3746-60
references.pmid: 16675519
references.citation: J Neurochem. 1979 Jul;33(1):181-9
references.pmid: 458448
references.citation: J Physiol. 2007 Jul 15;582(Pt 2):539-51
references.pmid: 17495040
references.citation: Prog Biophys Mol Biol. 2004 Feb-Apr;84(2-3):197-215
references.pmid: 14769436
references.citation: Nat Neurosci. 2003 May;6(5):484-90
references.pmid: 12679782
references.citation: Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):12145-9
references.pmid: 1465453
references.citation: Neuron. 1993 Feb;10(2):165-75
references.pmid: 7679913
references.citation: J Pharmacol Exp Ther. 2005 Jun;313(3):1035-45
references.pmid: 15681656
references.citation: J Neurophysiol. 2004 Jan;91(1):267-73
references.pmid: 14715720
references.citation: Am J Physiol. 1998 Nov;275(5):R1523-9
references.pmid: 9791069
references.citation: Trends Neurosci. 2004 May;27(5):262-9
references.pmid: 15111008
references.citation: Pharmacol Ther. 1997;73(2):121-46
references.pmid: 9131721
references.citation: J Neurosci. 2006 Apr 19;26(16):4216-27
references.pmid: 16624942
references.citation: Neurochem Res. 2000 Oct;25(9-10):1241-4
references.pmid: 11059798
references.citation: Am J Physiol Regul Integr Comp Physiol. 2002 Apr;282(4):R1006-15
references.pmid: 11893604
references.citation: Pflugers Arch. 1994 Nov;429(1):140-2
references.pmid: 7708474
references.citation: J Neurophysiol. 2002 Mar;87(3):1348-62
references.pmid: 11877509
references.citation: J Neurochem. 1988 Mar;50(3):818-23
references.pmid: 3339356
references.citation: Science. 1990 Sep 14;249(4974):1303-6
references.pmid: 1975955
references.citation: J Pharmacol Exp Ther. 2007 Feb;320(2):615-26
references.pmid: 17071818
references.citation: J Neurophysiol. 1996 Apr;75(4):1573-88
references.pmid: 8727397
references.citation: Neuropharmacology. 2007 Jun;52(7):1439-53
references.pmid: 17433821
references.citation: Am J Physiol Heart Circ Physiol. 2008 Aug;295(2):H807-15
references.pmid: 18567709
references.citation: Neurochem Int. 1996 Oct;29(4):335-56
references.pmid: 8939442
references.citation: J Neurosci. 2005 Dec 14;25(50):11553-63
references.pmid: 16354913
references.citation: J Neurosci. 2003 Apr 1;23(7):2618-26
references.pmid: 12684447
references.citation: J Physiol. 1998 Dec 1;513 ( Pt 2):521-30
references.pmid: 9807000
references.citation: J Neurophysiol. 2002 May;87(5):2624-8
references.pmid: 11976398
references.citation: J Neurosci. 2004 Sep 22;24(38):8379-82
references.pmid: 15385620
references.citation: J Biol Chem. 1992 Sep 5;267(25):17491-3
references.pmid: 1517200
references.citation: Hypertension. 2003 Dec;42(6):1124-9
references.pmid: 14597646
references.citation: Hypertension. 2003 Oct;42(4):725-31
references.pmid: 12900439
references.citation: Neuroscience. 2008 Jun 2;153(4):1332-43
references.pmid: 18440149
references.citation: J Neuroendocrinol. 2005 Jul;17(7):413-23
references.pmid: 15946159
references.citation: Pharmacol Biochem Behav. 2002 Mar;71(3):457-68
references.pmid: 11830180
references.citation: J Physiol. 1996 Dec 15;497 ( Pt 3):753-9
references.pmid: 9003560
references.citation: Nebr Med J. 1996 Dec;81(12):419-23
references.pmid: 9046793
references.citation: Neuroscience. 2003;118(3):585-601
references.pmid: 12710969
references.citation: J Biol Chem. 1993 Jan 25;268(3):2106-12
references.pmid: 8420981
references.citation: Hypertension. 2001 Feb;37(2 Pt 2):614-8
references.pmid: 11230344
references.citation: Neuroscience. 1999;89(4):1319-29
references.pmid: 10362317
references.citation: Exp Physiol. 2003 May;88(3):335-42
references.pmid: 12719758
references.citation: J Physiol. 2007 Aug 1;582(Pt 3):1219-38
references.pmid: 17525115
references.citation: J Neurosci Res. 2001 May 1;64(3):218-22
references.pmid: 11319765
references.citation: Physiol Rev. 2006 Jul;86(3):1009-31
references.pmid: 16816144
references.citation: J Neurosci. 2003 Mar 15;23(6):2032-9
references.pmid: 12657661
references.citation: J Neurophysiol. 2001 Dec;86(6):2823-33
references.pmid: 11731539
references.citation: Hypertension. 1999 Dec;34(6):1301-7
references.pmid: 10601134
references.citation: Clin Exp Pharmacol Physiol. 1998 Jun;25(6):461-3
references.pmid: 9673825
references.citation: Brain Res. 1998 Aug 10;801(1-2):239-43
references.pmid: 9729407
references.citation: Neuroscience. 2003;117(2):337-46
references.pmid: 12614674
references.citation: Neurosci Lett. 1992 Nov 23;147(1):16-20
references.pmid: 1336151
references.citation: Nat Rev Neurosci. 2006 May;7(5):335-46
references.pmid: 16760914
references.citation: J Neurophysiol. 2005 Sep;94(3):2073-85
references.pmid: 15987761
references.citation: Neuroscience. 2000;100(3):549-56
references.pmid: 11098118
references.citation: Glia. 2004 Aug 15;47(3):258-67
references.pmid: 15252815
references.citation: Pflugers Arch. 2004 Nov;449(2):132-42
references.pmid: 15338308
references.citation: Br J Pharmacol. 1994 Oct;113(2):536-40
references.pmid: 7834205
references.citation: J Comp Neurol. 1980 Dec 1;194(3):555-70
references.pmid: 7451682
references.citation: Annu Rev Physiol. 2001;63:795-813
references.pmid: 11181976
references.citation: Neuron. 1998 Apr;20(4):783-95
references.pmid: 9581769
references.citation: Neuron. 2002 Feb 14;33(4):625-33
references.pmid: 11856535
references.citation: Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):2151-5
references.pmid: 14766975
references.citation: Brain Res Mol Brain Res. 1994 Oct;26(1-2):47-54
references.pmid: 7854065
references.citation: Acta Physiol Scand. 2003 Jan;177(1):17-26
references.pmid: 12492775
references.citation: Neuroscience. 1998 Apr;83(3):815-28
references.pmid: 9483565
references.citation: Brain Res. 1998 Apr 27;791(1-2):317-20
references.pmid: 9593966
references.citation: J Physiol. 2003 Apr 1;548(Pt 1):97-110
references.pmid: 12588900
references.citation: J Neurophysiol. 2003 Oct;90(4):2690-701
references.pmid: 12815026
references.citation: Trends Neurosci. 2004 Jan;27(1):30-40
references.pmid: 14698608
references.citation: Brain Res Brain Res Rev. 2004 Jul;45(3):196-212
references.pmid: 15210304
references.citation: J Neurosci. 1996 Oct 1;16(19):6255-64
references.pmid: 8815906
references.citation: Neuron. 2003 Dec 18;40(6):1059-61
references.pmid: 14687541
references.citation: Nature. 2001 Jan 4;409(6816):88-92
references.pmid: 11343119
references.citation: Eur J Neurosci. 1997 Mar;9(3):533-48
references.pmid: 9104595
references.citation: Am J Physiol. 1998 Sep;275(3):R728-34
references.pmid: 9728069
references.citation: Peptides. 2004 Mar;25(3):403-11
references.pmid: 15134863
references.citation: Eur J Pharmacol. 2003 Oct 31;479(1-3):127-37
references.pmid: 14612144
references.citation: J Comp Neurol. 1996 Apr 15;367(4):595-606
references.pmid: 8731228
references.citation: Trends Neurosci. 1994 Dec;17(12):517-25
references.pmid: 7532336
references.citation: Mol Pharmacol. 2003 Jan;63(1):2-8
references.pmid: 12488530
references.citation: J Neurosci. 2000 Jun 1;20(11):4091-8
references.pmid: 10818144
references.citation: Am J Physiol Heart Circ Physiol. 2006 Dec;291(6):H2847-56
references.pmid: 16877560
references.citation: Nat Rev Neurosci. 2005 Mar;6(3):215-29
references.pmid: 15738957
references.citation: J Physiol. 1998 Nov 1;512 ( Pt 3):643-9
references.pmid: 9769410
references.citation: Am J Physiol Heart Circ Physiol. 2001 Sep;281(3):H1233-41
references.pmid: 11514292
references.citation: Trends Neurosci. 1999 May;22(5):208-15
references.pmid: 10322493
references.citation: J Comp Neurol. 2006 Feb 1;494(4):673-85
references.pmid: 16374796
references.citation: Neuroscience. 1984 Jul;12(3):783-91
references.pmid: 6472620
references.citation: J Neurophysiol. 1992 Jun;67(6):1698-701
references.pmid: 1629773